Featured
-
ISH Global Hypertension Practice Guidelines
2020-11-16
Information and resources related to the 2020 ISH Global Hypertension Practice Guidelines
-
ISH Committee and Group Membership 2020-2022
2020-11-01
Following our highly successful virtual General Meeting in October the new ISH leadership structure was confirmed for the 2020-2022 period. Membership of the vast majority of Committees has been now ratified. Please see below.
-
ISH Hypertension News
2020-10-28
We are delighted to share with you the October 2020 issue of ISH Hypertension News.
ISH Hypertension News is available online @ http://ish-world.com/news/a/hypertensionnews/, ISSN: 2520-2782
You are viewing articles tagged with "During 12/2015".
-
Can we translate the results of SPRINT into clinical practice?
The much awaited results of the Systolic Blood Pressure Intervention Trial (SPRINT) have recently been published.
Read More 15/12/2015
-
Renew your ISH 2016 membership
Receive your annual subscription to the Journal of Hypertension, substantial savings on registration fees for the ISH Biennial Scientific Meetings and much more.
Read More 10/12/2015
-
An interview with Amit Tirosh - ISH December new investigator of the month
Amit is a Senior Endocrinologist at Rabin Medical Center, Israel. Visiting attending endocrinologist, National Institutes of Health. He is interested in the diagnosis of hypercortisolism, and in the prevention of its deleterious effects, including hypertension, hyperglycemia and hypercoagulability.
Read More 02/12/2015
-
Sex, drugs and trials galore
We are delighted to present you with the December 2015 issue of ISH Hypertension News.
This includes coverage of the results of four trials, all of which have important implications for clinical practice in relation to improving CVD prevention. Three of these trials - SPRINT and two PATHWAYS trials - have clinical implications for hypertension management (how low to go and how to do it) and one EMPA-REG provides unique data regarding optimal glucose lowering with a new class of agents for the prevention of CVD in patients with type 2 diabetes!Read More 02/12/2015